Russia may develop an analogue of the coronavirus drug that Trump was treated with
The N. F. Gamalei National Research Center for Epidemiology and Microbiology has received a grant to develop a drug for the treatment of a new coronavirus infection based on monoclonal antibodies – an analogue of the drug that was treated by US President Donald Trump. The results of the developments can be presented as early as the end of 2021, the director of the Center Alexander Ginzburg told TASS.
"Yes, in some areas we have now received grants and <...> one of my main laboratories is exclusively engaged in this [drug development]. These are monoclonal antibodies, these are actually the antibodies that protect [from the virus and are] in the plasma of those who have been ill, only which will be obtained genetically engineered outside the human body and in concentrated form, - said Ginzburg – By the end of next year, I think I will tell you about the positive results, and maybe even earlier maybe even in the fall."
The scientist shared that the center is also working on creating a vaccine that will simultaneously protect against the new coronavirus and influenza. "We have worked out the technology on rotaviruses, and already on such a variant of communication related to coronavirus, [it can be investigated] closer to the end of the coming year. But this is a universal technology that should, in principle, make it possible to create vaccine preparations for different strains of the same pathogen at once <...> or even for different viruses, like coronavirus and influenza virus, when it is necessary to actually protect a person at the same time," Ginzburg said.
"We are also creating all kinds of chemicals that should protect against nosocomial infections, this is the main cause of death of covid patients in the hospital when they are placed on artificial lung ventilation devices <...>. They die primarily from nosocomial infections. But this, of course, is not in a month or two, God forbid in a year it will all appear," he concluded.
As previously stated by Trump's attending physician Sean Conley, after the coronavirus was detected, the American leader took an experimental antibody-based serum produced by the American company Regeneron Pharmaceuticals. Trump himself said that he felt like a superman after taking the drug.
Portal "Eternal youth" http://vechnayamolodost.ru